Lenalidomide plus Rituximab for Mantle-Cell Lymphoma. uri icon

Overview

publication date

  • February 25, 2016

Research

keywords

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols
  • Lymphoma, Mantle-Cell
  • Thalidomide

Identity

Scopus Document Identifier

  • 84960957342

Digital Object Identifier (DOI)

  • 10.1056/NEJMc1515465

PubMed ID

  • 26933862

Additional Document Info

volume

  • 374

issue

  • 8